E-Mail
IMAGE: The Novo Nordisk Network for Healthy Populations will support innovative new research, catalyze existing research projects, strengthen partnerships in the health care and public health spheres and encourage community outreach. view more
Credit: University of Toronto
Novo Nordisk A/S and the University of Toronto have announced a C$40-million investment to establish the Novo Nordisk Network for Healthy Populations. Based at U of T Mississauga, the new network is a partnership between the Dalla Lana School of Public Health, the Temerty Faculty of Medicine and University of Toronto Mississauga. The network will focus on new ways to support healthier urban populations, and will draw on U of T s leading expertise in public health research and education programs to impact the global fight against diabetes and other serious chronic diseases.
E-Mail
IMAGE: Dr. Omar Albagha, one of the principal investigators of Whole genome sequencing in the Middle Eastern Qatari population identifies genetic associations with 45 clinically relevant traits , Nature Communications 2021 view more
Credit: Qatar Foundation
Doha, Qatar - (February 23, 2021) - A group of researchers at Qatar Foundation have reported the first and largest genetic association study in the Middle East, that has been published online in
Nature Communications - a leading a peer-reviewed, open access, scientific journal published by Nature Research.
The study titled Whole genome sequencing in the Middle Eastern Qatari population identifies genetic associations with 45 clinically relevant traits highlights a vital piece of information wherein now there is a better understanding of the genetic risk factors that are specific to the Arab population, including those that are shared with other ethnicities.
There is growing evidence that ketone bodies may be beneficial to heart disease patients regardless of the method of delivery used to increase ketone delivery to the heart. A Journal of the American College of Cardiology review paper examines emerging evidence regarding ketone bodies effects on the heart and the potential for ketone therapy as a cardiovascular intervention in heart disease patients.
E-Mail
IMAGE: Scientists from Japan and the United States have identified a new mechanism of blood-brain barrier degradation in the post-stroke brain, involving acrolein-induced modifications of proheparanase. This discovery could lead to. view more
Credit: Toubibe from Pixabay
Strokes are a leading cause of poor quality of life or even death in Japan and the world over. Since its characterization, several researchers have been working tooth and nail to identify drug-accessible and effective therapeutic targets for this debilitating condition. One such region of interest for drug targets is the blood-brain barrier (BBB).
The BBB is a structure located around the brain, which prevents the entry of unnecessary circulating cells and biomolecules into the brain. The blood vessels in the BBB are coated with a distinct and protective layer of sugar, called the endothelial glycocalyx, which prevents their entry. However, in the event of a stroke, which results in the blocka